{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:41:48Z","timestamp":1773020508977,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Case Reports"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/j.ebcr.2016.09.006","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T03:25:33Z","timestamp":1479353133000},"page":"28-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Unmasking of myoclonus by lacosamide in generalized epilepsy"],"prefix":"10.1016","volume":"7","author":[{"given":"Daniel","family":"Birnbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Koubeissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ebcr.2016.09.006_bb0005","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.yebeh.2012.06.024","article-title":"Epidemiology of juvenile myoclonic epilepsy","volume":"28","author":"Camfield","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.ebcr.2016.09.006_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11940-011-0131-z","article-title":"Treatment options in juvenile myoclonic epilepsy","volume":"13","author":"Mantoan","year":"2011","journal-title":"Curr Treat Options Neurol"},{"issue":"8","key":"10.1016\/j.ebcr.2016.09.006_bb0015","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1212\/WNL.55.8.1106","article-title":"Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?","volume":"55","author":"Genton","year":"2000","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ebcr.2016.09.006_bb0020","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.0013-9580.2004.19704.x","article-title":"Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies","volume":"45","author":"Gelisse","year":"2004","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ebcr.2016.09.006_bb0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1755-5949.2008.00046.x","article-title":"Treatment of juvenile myoclonic epilepsy","volume":"14","author":"Auvin","year":"2008","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10.1016\/j.ebcr.2016.09.006_bb0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.seizure.2011.12.010","article-title":"Lacosamide treatment of juvenile myoclonic epilepsy","volume":"21","author":"Afra","year":"2012","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.ebcr.2016.09.006_bb0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","volume":"30","year":"1989","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ebcr.2016.09.006_bb0040","first-page":"115","article-title":"Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy","volume":"122","author":"Jayalakshmi","year":"2010","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"10.1016\/j.ebcr.2016.09.006_bb0045","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/j.1528-1167.2009.02110.x","article-title":"Epileptic discharges and phasic sleep phenomena in patients with juvenile myoclonic epilepsy","volume":"50","author":"Bonakis","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ebcr.2016.09.006_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.ebcr.2016.09.006_bb0060","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/15563650.2013.818685","article-title":"A case series of patients with lamotrigine toxicity at one center from 2003 to 2012","volume":"51","author":"Moore","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"issue":"12","key":"10.1016\/j.ebcr.2016.09.006_bb0065","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/j.1528-1167.2006.00829.x","article-title":"Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease","volume":"47","author":"Genton","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebcr.2016.09.006_bb0070","series-title":"The epilepsies: seizures, syndromes and management","author":"Panayiotopoulos","year":"2005"},{"issue":"1","key":"10.1016\/j.ebcr.2016.09.006_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0883073812462887","article-title":"Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy","volume":"29","author":"Yorns","year":"2014","journal-title":"J Child Neurol"}],"container-title":["Epilepsy & Behavior Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323216300962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323216300962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T16:53:02Z","timestamp":1536252782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213323216300962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":14,"alternative-id":["S2213323216300962"],"URL":"https:\/\/doi.org\/10.1016\/j.ebcr.2016.09.006","relation":{},"ISSN":["2213-3232"],"issn-type":[{"value":"2213-3232","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmasking of myoclonus by lacosamide in generalized epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebcr.2016.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}